Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants

Abstract The emergence of SARS-CoV-2 variants has underscored the urgent need for innovative vaccine strategies that provide robust and enduring protection against diverse strains. Our study introduces the FP-HR5 nanoparticle vaccine, designed to target the highly conserved S2 subunit of the spike p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chaofeng Liang, Rong Li, Zeyu Pu, Ran Chen, Yuzhuang Li, Siqi Chen, Jinzhu Feng, Jie Liu, Yuteng Bai, Xuewen Qin, Chengjie Xie, Yixin Zhang, Yi Peng, Hui Tang, Mei Zhang, Qiuyue Zhang, Tao Wang, Baisheng Li, Huan Zhang, Xu Zhang, Yun He, Xin He, Ting Pan, Hui Zhang, Yiwen Zhang
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Journal of Nanobiotechnology
Subjects:	SARS-CoV-2 Broad-spectrum vaccine Conserved epitopes Nanoparticle vaccine Mucosal immunity Respiratory viruses
Online Access:	https://doi.org/10.1186/s12951-025-03582-w
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants

Similar Items